Partner Content Partner Content Key Questions To Boost Your KOL Management– Part 1/8: KOL Id... Introduction to KOL identification and it's value
Partner Content Partner Content Validating Your KOLs Validating your KOLs for an evolving KOL landscape
Partner Content Partner Content The Problem of the Hyperprolific Author When It Comes to KOL... The dangers of hyper-prolific authors
R&D Reuters Pharma USA 2024 – Meruno Perugini Innovation in pharma comes in many forms, but at the end of the day what the industry cares about is results.
Digital Fixing clinical trial data management It’s 2024, and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another.
